A novel Germline mutation in <i>HOXB13</i> is associated with prostate cancer risk in Chinese men

Xiaoling Lin(Sun Yat-sen University), Jianfeng Xu(NorthShore University HealthSystem), Fangjian Zhou(Sun Yat-sen University), Qi‐Jun Wu(Sun Yat-sen University), Guozeng Wang(Fuzhou University), Jin Yang(University of Electronic Science and Technology of China), Jianlin Yuan(Xijing Hospital), Zengnan Mo(Guangxi Medical University), Yang Jiao(Beihua University), Dingwei Ye(Fudan University Shanghai Cancer Center), Zhong Wang(Nanfang Hospital), Jielin Sun(Wake Forest University), Shasha Tao(University of Nottingham), Aubrey R. Turner(Wake Forest University), Shancheng Ren(Shanghai Changzheng Hospital), Qiang Ding(Nanjing Medical University), Qiang Shao(Chinese Academy of Sciences), Denglong Wu(Tongji University), Jun Qi(Hong Kong Baptist University), Zhuo Chen(Chinese Academy of Sciences), Xiang Wang(Peking University), Changjun Yin(Sun Yat-sen University), Fang Liu(Guangzhou University of Chinese Medicine), Haowen Jiang(Beijing Friendship Hospital), Zhengdong Zhang(Nanjing Medical University), Yinghao Sun(China Medical University), Shusen Zheng(Wenzhou University), Daru Lu(Institute of Biomedical Science), Xīn Gào(Qingdao University), Zhiwen Chen(Guangzhou University of Chinese Medicine), Yong Xu(Hubei University of Medicine), Dalin He(Sichuan University), Lianxi Qu(Huashan Hospital), Gongxian Wang(Nanchang University), Chuanliang Xu(Second Military Medical University), Yao Zhu(China Pharmaceutical University), Rong Shi(University of Science and Technology of China), Meilin Wang(Xiamen University), Ying Zheng(Guangzhou University of Chinese Medicine), Rong Na(Chinese University of Hong Kong), Jun Ouyang(Shandong University), Dong Pei(Sun Yat-sen University)
The Prostate
June 21, 2012
Cited by 83


Related Papers